Antidepressants, benzodiazepines and azapirones for panic disorder in adults: A network meta-analysis

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Giuseppe Guaiana - , Western University (Autor:in)
  • Corrado Barbui - , University of Verona (Autor:in)
  • Deborah M. Caldwell - , University of Bristol (Autor:in)
  • Simon J.C. Davies - , University of Toronto (Autor:in)
  • Toshi A. Furukawa - , Kyoto University (Autor:in)
  • Hissei Imai - , Kyoto University (Autor:in)
  • Markus Koesters - , Universität Ulm (Autor:in)
  • Aran Tajika - , Kyoto University (Autor:in)
  • Irene Bighelli - , Technische Universität München (Autor:in)
  • Alessandro Pompoli - (Autor:in)
  • Andrea Cipriani - , Oxford Health NHS Foundation Trust (Autor:in)

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare individual active drugs (antidepressants, benzodiazepines and azapirones) and placebo in terms of efficacy and acceptability in the acute treatment of panic disorder, with or without agoraphobia. To rank treatments for panic disorder (antidepressants, benzodiazepines, azapirones and placebo) according to their effectiveness and acceptability.

Details

OriginalspracheEnglisch
AufsatznummerCD012729
FachzeitschriftCochrane database of systematic reviews
Jahrgang2017
Ausgabenummer7
PublikationsstatusVeröffentlicht - 31 Juli 2017
Peer-Review-StatusJa
Extern publiziertJa

Externe IDs

ORCID /0000-0001-7018-6021/work/168207868

Schlagworte

ASJC Scopus Sachgebiete